SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high has fueled buyout speculationoften centered on Sanofiand hopes for a short squeeze, with traders also pointing to heavy call-option activity. BRIUMVIs commercial growth and forthcoming earnings and subcutaneous data add to the optimism, while some traders doubt a deal is imminent and see the rally as momentum ahead of results.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,589,443 with 63,351,197,653 in circulation. The last known price of XRP is 1.24455819 USD and is down -0.63 over the last 24 hours. It is currently trading on 1893 active market(s) with $917,900,293.08 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is under pressure amid a broader crypto selloff linked by traders to the Binance hack, while Ripples Swell announcements have drawn disappointment over the tokens muted response. The main debate is whether Ripples partnerships, bank charter and RLUSD growth will create demand for XRP, or primarily benefit Ripple and its stablecoin instead.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming Q3 report is the dominant focus, with traders debating whether strong results and raised guidance can clear an already high bar as AI stocks face a broader pullback. Bulls expect continued growth, while skeptics warn that a beat may not prevent selling given the stocks lofty valuation and risk-off sentiment.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to Iran-related tensions and reported threats to oil shipments through the Strait of Hormuz, which have fueled concerns about supply disruptions and supported crude prices. Bulls see further risk from possible escalation and depleted reserves, while bears expect a sharp pullback if negotiations produce a deal or tensions ease.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Hopes for U.S.-Iran de-escalation are weighing on crude prices and UCO, while persistent concerns about Strait of Hormuz disruptions and constrained supply keep some traders bullish. The community is debating whether diplomacy will ease the oil-risk premium or whether renewed conflict will sustain sharp swings.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Traders are focused on the Iran conflict, Strait of Hormuz shipping risks and reported attacks on energy infrastructure, with concerns about disrupted oil and fuel supply supporting interest in energy stocks. The community is split between those expecting further gains if tensions persist and those warning that diplomacy, easing supply fears or profit-taking could reverse the rally.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion is dominated by the midterm elections and Trumps political fortunes, with traders debating how the outcome could affect DJT and broader markets; speculation over Iran-war escalation and oil prices adds to the uncertainty. Sentiment is mostly bearish, with posts citing DJTs sharp decline and weak fundamentals, though some traders anticipate a rebound.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

Hinge Health to announce third quarter 2026 financial results on November 2, 2026

Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30...

Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876

Key PointsThe transaction reduced her direct equity position by 4% while maintaining a multi-million dollar stake in the company...

Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including artificial intelligence, to automate care for joint and muscle health, delivering member experience, member outcomes, and cost reductions for its clients. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

Hinge Health Inc. - Ordinary Shares - Class A

Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Care

Equity

Bullish Sentiment

Hinge Health received widespread bullish initiation coverage on Monday from a dozen brokerages, with analysts highlighting its leadership in digital musculoskeletal (MSK) care, strong margins, and scalable AI platform.The stock ended 3.9% higher at $36.21 on Monday.Piper SandlerPiper Sandler started the stock at ‘Overweight’ with a $41 target, noting Hinge’s proprietary technology and sophisticated distribution strategy as drivers for sustained double-digit revenue growth.&nbsp;The firm pointed to a 2.4x or greater return on investment across commercial and Medicare populations, with durable 80%-plus gross margins and operating leverage as the company scales beyond its 2,250 clients and 20 million contracted lives as of Dec. 31, 2024.CanaccordCanaccord also began with a ‘Buy’ rating and a $52 target, describing Hinge as a “true innovator” disrupting traditional physical therapy through an AI-powered platform.&nbsp;The firm cited automation of 95% of care and emphasized the defensibility of Hinge’s position in the digital MSK market.BofABofA launched coverage with a ‘Buy’ rating and $42 target, calling Hinge the “digital physical therapy leader” with competitive advantages in its customer base, motion-tracking tech, and partnerships with five of the largest U.S. health plans.NeedhamNeedham began coverage with a ‘Buy’ rating and $47 target, calling Hinge the market leader in virtual MSK care and pointing to its advantages over digital competitors and legacy in-person providers.&nbsp;The firm noted that while 40% of Americans suffer from MSK issues, only 9% get treatment, creating a large untapped opportunity.William BlairWilliam Blair rated the stock ‘Outperform’ and described it as a core healthcare technology holding.&nbsp;The firm pointed to Hinge’s personalized digital app and supportive valuation at 5x 2026 revenue and 6.4x adjusted gross profit.Evercore ISIEvercore ISI also rated the stock ‘Outperform’ with a $50 target, citing broad employer and plan adoption and a multi-condition offering that supports continued 20% annual growth.TruistTruist gave it a ‘Buy’ rating and&nbsp;a $48 target, highlighting “enduring structural advantages,” strong outcomes data, and a flywheel driven by AI, partner networks, and attractive economics.StifelStifel started Hinge with a ‘Buy’ and $48 target, describing a platform that combines mobile app-based care with messaging and licensed PTs.&nbsp;The firm noted that Hinge became profitable and free cash flow positive in 2024, with room for further margin gains.RBC CapitalRBC Capital gave an ‘Outperform’ rating and&nbsp;a $45 target, saying the firm is well-positioned to scale digital MSK care across commercial, Medicare Advantage, and global markets, supported by strong validation and 20M covered lives.KeyBancKeyBanc began with an ‘Overweight’ and $45 target, describing Hinge as the clear leader in a large and underserved healthcare segment.&nbsp;The firm believes the recent 17% decline in share price post-IPO presents an attractive entry point.BarclaysBarclays also rated the stock ‘Overweight’ with a $43 target, saying Hinge can “bend the cost curve” in MSK with its tech and partnerships, and sees 15–20% billings growth translating into 20% revenue expansion.On Stocktwits, retail sentiment was ‘bearish’ amid ‘low’ message volume.The stock has declined 3.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Hinge Health logo is seen displayed on a smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.

Hinge Health, Inc.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$HNGE First position in my public paper book: 25 shares at this morning’s open. Earnings Nov 2. Every trade timestamped. Not advice.

Bob Ford

$HNGE Week one in my public paper book. Earnings Nov 2 after the close. I’ll post the exit when it happens, win or lose. That’s the deal. It’s looking good for now tho!

Closed $HNGE in my public paper book at Monday’s open, ahead of the Nov. 2 report, per the exit rule I set at entry. +14.6% on the trade. Next one will get the same rules, but for now I’m sitting on cash waiting for a good opportunity.

$HNGE Getting tighter every day.. Not the angle of flag i like but could work on 100 century mark breakout. No positiion

Feed

News

Sentiment

Earnings

Fundamentals

Info

HNGE Hinge Health, Inc.

Fundamentals

Latest HNGE News